Cargando…
Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials
Diabetes mellitus is the most common endocrine disorder worldwide, with over 20% of patients ultimately developing diabetic kidney disease (DKD), a complex nephropathic complication that is a leading cause of end-stage renal disease. Various clinical trials have utilized probiotics, prebiotics, and...
Autores principales: | Paul, Pradipta, Kaul, Ridhima, Chaari, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740604/ https://www.ncbi.nlm.nih.gov/pubmed/36499168 http://dx.doi.org/10.3390/ijms232314838 |
Ejemplares similares
-
The Promising Role of Microbiome Therapy on Biomarkers of Inflammation and Oxidative Stress in Type 2 Diabetes: A Systematic and Narrative Review
por: Paul, Pradipta, et al.
Publicado: (2022) -
Can probiotic, prebiotic, and synbiotic supplementation modulate the gut-liver axis in type 2 diabetes? A narrative and systematic review of clinical trials
por: Al-Najjar, Yousef, et al.
Publicado: (2022) -
Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review
por: Kaul, Ridhima, et al.
Publicado: (2021) -
A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle
por: Kumar, Sanjay, et al.
Publicado: (2022) -
Knowledge, Awareness, and Attitude of Healthcare Stakeholders on Alzheimer’s Disease and Dementia in Qatar
por: Paul, Pradipta, et al.
Publicado: (2023)